Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anne, Stürzebecher"'
Autor:
Michael Deters, Anne Stürzebecher
Publikováno v:
Deutsches Ärzteblatt international.
Autor:
Mandy Gollmann, Gesine Liebetrau, Dagmar Prasa, Michael Deters, Anne Stürzebecher, S. Just, Germaine Frimlova
Publikováno v:
Das Gesundheitswesen. 81:397-404
Zusammenfassung Ziel der Studie Substanzmissbrauch war in den letzten Jahren starken Veränderungen unterworfen und ist eine große Herausforderung für die Klinische Toxikologie. Deswegen wurden Substanzmissbrauchsfälle der letzten 15 Jahre im Einz
Autor:
Mandy, Gollmann, Germaine, Frimlova, Simone, Just, Gesine, Liebetrau, Dagmar, Prasa, Anne, Stürzebecher, Michael, Deters
Publikováno v:
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 81(5)
Poisoning due to substance abuse has changed significantly during the last few years. Therefore, developments of substance abuse reported to the Poisons Information Centre Erfurt were investigated and compared to other circumstances of human exposure
Autor:
Andrea Schweinitz, Rainer Friedrich, Manuel E. Than, Daniel Dönnecke, Anne Stürzebecher, Jörg Stürzebecher, Wolfram Bode, Friedemann Müller, Torsten Steinmetzer, Oliver Schuster, Peter Steinmetzer, Kerstin Uhland
Publikováno v:
Journal of Medicinal Chemistry. 49:4116-4126
Matriptase is an epithelium-derived type II transmembrane serine protease and has been implicated in the activation of substrates such as pro-HGF/SF and pro-uPA, which are likely involved in tumor progression and metastasis. Through screening, we hav
Autor:
Andrea Schweinitz, Peter Steinmetzer, Joscha Kotthaus, Bernd Clement, Torsten Steinmetzer, Jörg Stürzebecher, Oliver Schuster, Daniel Dönnecke, Uta Stürzebecher, Anne Stürzebecher
Publikováno v:
ChemMedChem. 2(7)
A series of highly potent substrate-analogue factor Xa inhibitors containing D-homophenylalanine analogues as the P3 residue has been identified by systematic optimization of a previously described inhibitor structure. An initial lead, benzylsulfonyl
Autor:
Daniel Dönnecke, Torsten Steinmetzer, Maj Schuster, Anne Stürzebecher, Uta Stürzebecher, Silke Nicklisch, Andrea Schweinitz, Peter Steinmetzer, Jörg Stürzebecher
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(12)
Highly potent and selective substrate analogue factor Xa inhibitors were obtained by incorporation of non-basic or modestly basic P1 residues known from the development of thrombin inhibitors. The modification of the P2 and P3 amino acids strongly in
New substrate analogue inhibitors of factor Xa containing 4-amidinobenzylamide as P1 residue: part 1
Autor:
Andrea Schweinitz, Oliver Schuster, Torsten Steinmetzer, Anne Stürzebecher, Uta Stürzebecher, Jörg Stürzebecher
Publikováno v:
Medicinal chemistry (Shariqah (United Arab Emirates)). 2(4)
The trypsin-like serine protease factor Xa (fXa) is located at the convergence point of the intrinsic and extrinsic coagulation cascade, and therefore has emerged as an attractive target for the design of novel anticoagulants. During the development
Autor:
Torsten Steinmetzer, Maria C Stella, Kerstin Uhland, Stefan Thiel, Andrea Schweinitz, Jörg Stürzebecher, Anne Stürzebecher, Diana Förbs
Publikováno v:
International Journal of Oncology.
Matriptase, also known as membrane-type-serine-protease 1 (MT-SP 1), is a type II transmembrane serine protease involved in the activation of the precursor form of hepatocyte growth factor/scatter factor (pro-HGF/SF). Since HGF/SF is a well-known ext
Autor:
Andreas Geissler, Anne Stürzebecher, Torsten Steinmetzer, Helmut Giersiefen, Ewa Zeslawska, Matthias J.E. Arlt, Uwe Jacob, Achim Krüger, Jörg Stürzebecher, Andrea Schweinitz, Ingo J. Banke, Oliver Schuster
Publikováno v:
The Journal of biological chemistry. 279(32)
The serine protease urokinase-type plasminogen activator (uPA) interacts with a specific receptor (uPAR) on the surface of various cell types, including tumor cells, and plays a crucial role in pericellular proteolysis. High levels of uPA and uPAR of